A recent report compiled by a researcher at the University of Malta, Francesco Borg, together with Giuseppe Di Giovanni, from Cardiff University indicates that medical cannabis may treat Parkinson’s disease and also hinder its development. This report which highlighted this finding is called Xjenza and emphasised on the role played by cannabinoids which serve as a solid option for treating people suffering from Parkinson’s disease.
It is a complicated disease which mostly impacts the elderly, and no cure exists at this point. Considering that existing treatments have their flaws, science needs to invest in more sophisticated forms of combatting Parkinson’s disease.
The treatment available today does not serve to hinder or stop the development of Parkinson’s disease. It only serves to make up for the lack of dopamine in the brain. This illustrates the fact that there is no cure today for this disease. This is accompanied by the fact that following years of such ineffective treatment, effects such as dyskinesia, which refers to inability and impairment of voluntary movement, may appear.
The report argues strongly in favour of medical cannabis and that it has been used as a therapeutic agent for a good number of years. By the middle of the nineteenth century, cannabis was recognised as a medicinal compound. The drug has been used extensively in the medicinal sphere, having treated inflammation, pain, oxidative stress and Parkinson’s disease.
The report also highlights that medical cannabis would help with sleep, depression and pain.
Parkinson’s disease, one of the most common neurodegenerative disorders, falling only second to Alzheimer’s disease, affects one percent of the world population. The study emphasises on the fact that by 2030, there will be around nine million cases. This figure is expected to be split across the most populated countries in the world.
What is your view on all this? Do you agree with medicinal cannabis? Let us know in the comments section.